Inactive Instrument
InterCure Ltd. Stock TEL AVIV STOCK EXCHANGE
Stocks
INCR
IL0011063760
Healthcare Facilities & Services
| Market Cap | 144M 417M 124M 114M 107M 201M 13.58B 203M 1.35B 526M 6.65B 539M 528M 23.01B | P/E Ratio 2024 |
-4.01x | P/E Ratio 2025 | -4.87x |
|---|---|---|---|---|---|
| Enterprise Value | 280M 812M 241M 222M 208M 391M 26.47B 395M 2.63B 1.03B 12.96B 1.05B 1.03B 44.85B | EV / Sales 2024 |
1.69x | EV / Sales 2025 | 1.16x |
| Free-Float |
73.95% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.22% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 55 | 24/12/2019 | |
Amos Cohen
DFI | Director of Finance/CFO | 47 | 01/03/2020 |
Itai Kabiljo
LAW | General Counsel | - | 01/04/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 50 | 03/09/2015 | |
David Salton
BRD | Director/Board Member | 66 | 14/12/2014 |
| Chairman | 55 | 13/02/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.22% | -0.51% | - | - | 49.24M | |
| -3.02% | -3.97% | -25.26% | -34.09% | 150M | |
| -0.59% | +1.20% | +33.07% | +85.71% | 120M | |
| +1.89% | -6.90% | +89.47% | -19.40% | 108M | |
| +3.17% | -7.51% | +72.09% | +18.95% | 95.12M | |
| Average | +0.41% | -1.98% | +42.35% | +12.79% | 118.3M | |
| Weighted average by Cap. | +0.08% | -1.54% | +35.22% | +10.36% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 239M 693M 206M 189M 178M 334M 22.57B 337M 2.24B 875M 11.05B 896M 877M 38.25B | 270M 783M 233M 214M 201M 378M 25.54B 381M 2.53B 990M 12.51B 1.01B 992M 43.27B |
| Net income | -67.8M -197M -58.43M -53.78M -50.45M -94.77M -6.41B -95.71M -636M -248M -3.14B -254M -249M -10.86B | -35.71M -104M -30.78M -28.33M -26.57M -49.92M -3.37B -50.42M -335M -131M -1.65B -134M -131M -5.72B |
| Net Debt | 133M 385M 114M 105M 98.79M 186M 12.55B 187M 1.24B 486M 6.14B 498M 488M 21.26B | 136M 395M 118M 108M 101M 191M 12.88B 192M 1.28B 499M 6.31B 512M 501M 21.83B |
Employees
-
